Effects of Endurance Training Combined with Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients

Schizophrenia Bulletin

Volumn 41, Issue 4, 2015, Pages 847-858

  Malchow, Berend ^a   Keller, Katriona ^a,b   Hasan, Alkomiet ^a   Dörfler, Sebastian ^b   Schneider Axmann, Thomas ^a   Hillmer Vogel, Ursula ^b   Honer, William G ^c   Schulze, Thomas G ^a   Niklas, Andree ^b   Wobrock, Thomas ^b,d   Schmitt, Andrea ^a,e   Falkai, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Darmstadt Dieburg Clinics   (Germany)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

aerobic exercise; cognitive remediation; endurance training; everyday functioning; schizophrenia

Indexed keywords

ADAPTATION; ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; COGNITION; COGNITIVE REMEDIATION THERAPY; COMPUTER ASSISTED COGNITIVE REMEDIATION TRAINING; CONTROLLED STUDY; DISEASE SEVERITY; ENDURANCE TRAINING; ENVIRONMENT; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HOUSEHOLD; HUMAN; LEISURE; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCCER; SOCIAL ADJUSTMENT SCALE II; VERBAL LEARNING MEMORY TEST; WISCONSIN CARD SORTING TEST; COGNITION DISORDERS; COMPLICATION; CONTROLLED CLINICAL TRIAL; ENDURANCE; EXERCISE; FOLLOW UP; LEARNING; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSIOLOGY;

ADULT; COGNITION DISORDERS; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL ENDURANCE; PRACTICE (PSYCHOLOGY); SCHIZOPHRENIA;

EID: 84936742330     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv020     Document Type: Article

References (48)

1. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718-779.
2. Häfner H, Van der Heiden W. The course of schizophrenia in the light of modern follow-up studies: The ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci. 1999;249(suppl 4):14-26.
3. M?ller HJ, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. Eur Psychiatry. 2011;26:231-243.
4. Hafner H, Maurer K, Van der Heiden W. ABC Schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1021-1031.
5. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
6. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res. 2005;78:27-34.
7. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214-219.
8. Van der Heiden W, Häfner H. Course and outcome. In: Weinberger D, Harrison PJ, eds. Schizophrenia. Chichester, UK: Blackwell; 2010:104-141.
9. Kuipers E, Yesufu-Udechuku A, Taylor C, Kendall T. Management of psychosis and schizophrenia in adults: summary of updated NICE guidance. BMJ. 2014;348:g1173.
10. Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13:318-378.
11. Pajonk FG, Wobrock T, Gruber O, et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010;67:133-143.
12. Gorczynski P, Faulkner G. Exercise therapy for schizophrenia. Schizophr Bull. 2010;36:665-666.
13. Scheewe TW, Backx FJ, Takken T, et al. Exercise therapy improves mental and physical health in schizophrenia: A randomised controlled trial. Acta Psychiatr Scand. 2012;127:464-473.
14. Malchow B, Reich-Erkelenz D, Oertel-Kn?chel V, et al. The effects of physical exercise in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci. 2013;263:451-467.
15. Malchow B, Keeser D, Keller K, et al. Effects of endurance training on brain structures in chronic schizophrenia patients and healthy controls [published online ahead of print January 23, 2015]. Schizophr Res. doi: 10.1016/j.schres.2015.01.005.
16. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:1791-1802.
17. Eack SM, Hogarty GE, Cho RY, et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010;67:674-682.
18. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168:472-485.
19. Bor J, Brunelin J, d'Amato T, et al. How can cognitive remediation therapy modulate brain activations in schizophrenia? An fMRI study. Psychiatry Res. 2011;192:160-166.
20. Grynszpan O, Perbal S, Pelissolo A, et al. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: A meta-analytical study. Psychol Med. 2011;41:163-173.
21. WHO. International Statistical Classification of Diseases and Related Health Problems 10th Revision. 4th ed. Geneva, Switzerland: WHO; 2010.
22. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33; quiz 34-57.
23. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
24. Association AP. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., revised ed. Washington, DC: American Psychiatric Association; 1994.
25. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
26. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 1978;166:317-326.
27. Guy, W. Clinical global impressions. In: DHEW ed. ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW PublNo ADM 76-338). Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976, 218-222.
28. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: The Calgary Depression Scale. Br J Psychiatry Suppl. 1993:39-44.
29. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff "? Schizophr Bull. 2000;26:119-136.
30. Harvey PD, Green MF, Keefe RS, Velligan DI. Cognitive functioning in schizophrenia: A consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry. 2004;65:361-372.
31. Müller H, Hasse-Sander I, Horn R, Helmstaedter C, Elger CE. Rey Auditory-Verbal Learning Test: structure of a modified German version. J Clin Psychol. 1997;53:663-671.
32. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin Card Sorting Test-64 Card Version Professional Manual. Odessa, FL: Psychological Assessment Resources; 1993.
33. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
34. Faul F, Erdfelder E, Lang AG, Buchner A. G∗Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Meth. 2007;39:175-191.
35. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol. 1989;4:95-104.
36. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663-667.
37. Correll CU, Kishimoto T, Nielsen J, Kane JM. Quantifying clinical relevance in the treatment of schizophrenia. Clin Therapeut. 2011;33:B16-B39.
38. Roy-Byrne P, Dagadakis C, Unutzer J, Ries R. Evidence for limited validity of the revised global assessment of functioning scale. Psychiatr Serv. 1996;47:864-866.
39. Samara MT, Engel RR, Millier A, Kandenwein J, Toumi M, Leucht S. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. Eur Neuropsychopharmacol. 2014;24:1767-1772.
40. Vancampfort D, Probst M, Scheewe T, Knapen J, De Herdt A, De Hert M. The functional exercise capacity is correlated with global functioning in patients with schizophrenia. Acta Psychiatr Scand. 2012;125:382-387.
41. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334-1359.
42. Oertel-Kn?chel V, Mehler P, Thiel C, et al. Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. 2014;264:589-604.
43. Scheewe TW, Backx FJ, Takken T, et al. Exercise therapy improves mental and physical health in schizophrenia: A randomised controlled trial. Acta Psychiatr Scand. 2013;127:464-473.
44. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs. 2005;26:661-676.
45. Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add-on treatment in the management of patients with schizophrenia-A randomized controlled trial. Acta Psychiatr Scand. 2007;116:226-232.
46. Marzolini S, Jensen B, Melville P. Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: A multidisciplinary approach. Ment Health Phys Act. 2009;2:29-36.
47. Heggelund J, Nilsberg GE, Hoff J, Morken G, Helgerud J. Effects of high aerobic intensity training in patients with schizophrenia: A controlled trial. Nordic J Psychiatry. 2011;65:269-275.
48. Arnett JA, Labovitz SS. Effect of physical layout in performance of the Trail Making Test. Psychological Assessment Jun 1995 1995;7:220-221.